Active 0 6 0 6 O
autoimmune 7 17 7 17 B-chronic_disease
disease 18 25 18 25 I-chronic_disease
that 26 30 26 30 O
has 31 34 31 34 O
required 35 43 35 43 O
systemic 44 52 44 52 B-treatment
treatment 53 62 53 62 I-treatment
in 63 65 63 65 O
past 66 70 66 70 B-upper_bound
2 71 72 71 72 I-upper_bound
years 73 78 73 78 I-upper_bound

Active 0 6 79 85 B-chronic_disease
infection 7 16 86 95 I-chronic_disease
requiring 17 26 96 105 O
systemic 27 35 106 114 B-treatment
therapy 36 43 115 122 I-treatment

Advanced 0 8 123 131 O
melanoma 9 17 132 140 B-cancer
or 18 20 141 143 O
PD 21 23 144 146 O
- 23 24 146 147 O
L1 24 26 147 149 O
- 26 27 149 150 O
positive 27 35 150 158 O
advanced 36 44 159 167 O
, 44 45 167 168 O
relapsed 46 54 169 177 O
, 54 55 177 178 O
or 56 58 179 181 O
refractory 59 69 182 192 O
solid 70 75 193 198 B-cancer
tumor 76 81 199 204 I-cancer
or 82 84 205 207 O
lymphoma 85 93 208 216 B-cancer

Any 0 3 217 220 O
number 4 10 221 227 O
of 11 13 228 230 O
prior 14 19 231 236 B-treatment
treatment 20 29 237 246 I-treatment
regimens 30 38 247 255 I-treatment

Between 0 7 256 263 O
6 8 9 264 265 B-lower_bound
months 10 16 266 272 I-lower_bound
and 17 20 273 276 O
< 21 22 277 278 O
18 22 24 278 280 B-upper_bound
years 25 30 281 286 I-upper_bound
of 31 33 287 289 O
age 34 37 290 293 B-age

Currently 0 9 294 303 O
participating 10 23 304 317 O
and 24 27 318 321 O
receiving 28 37 322 331 O
study 38 43 332 337 O
therapy 44 51 338 345 B-treatment
in 52 54 346 348 O
, 54 55 348 349 O
or 56 58 350 352 O
has 59 62 353 356 O
participated 63 75 357 369 O
in 76 78 370 372 O
a 79 80 373 374 O
study 81 86 375 380 O
of 87 89 381 383 O
an 90 92 384 386 O
investigational 93 108 387 402 B-treatment
agent 109 114 403 408 I-treatment
and 115 118 409 412 O
received 119 127 413 421 O
study 128 133 422 427 O
therapy 134 141 428 435 O
or 142 144 436 438 O
used 145 149 439 443 O
an 150 152 444 446 O
investigational 153 168 447 462 B-treatment
device 169 175 463 469 I-treatment

Diagnosis 0 9 470 479 O
of 10 12 480 482 O
immunodeficiency 13 29 483 499 B-chronic_disease
or 30 32 500 502 O
receiving 33 42 503 512 O
systemic 43 51 513 521 B-treatment
steroid 52 59 522 529 I-treatment
therapy 60 67 530 537 I-treatment
or 68 70 538 540 O
any 71 74 541 544 O
other 75 80 545 550 O
form 81 85 551 555 O
of 86 88 556 558 O
immunosuppressive 89 106 559 576 B-treatment
therapy 107 114 577 584 I-treatment

Female 0 6 585 591 B-gender
participants 7 19 592 604 I-gender
of 20 22 605 607 O
childbearing 23 35 608 620 O
potential 36 45 621 630 O
must 46 50 631 635 O
be 51 53 636 638 O
willing 54 61 639 646 B-contraception_consent
to 62 64 647 649 I-contraception_consent
use 65 68 650 653 I-contraception_consent
2 69 70 654 655 I-contraception_consent
methods 71 78 656 663 I-contraception_consent
of 79 81 664 666 I-contraception_consent
contraception 82 95 667 680 I-contraception_consent
or 96 98 681 683 O
be 99 101 684 686 O
surgically 102 112 687 697 O
sterile 113 120 698 705 O

Female 0 6 706 712 B-gender
participants 7 19 713 725 I-gender
of 20 22 726 728 O
childbearing 23 35 729 741 O
potential 36 45 742 751 O
should 46 52 752 758 O
have 53 57 759 763 O
a 58 59 764 765 O
negative 60 68 766 774 B-pregnancy
urine 69 74 775 780 I-pregnancy
or 75 77 781 783 I-pregnancy
serum 78 83 784 789 I-pregnancy
pregnancy 84 93 790 799 I-pregnancy
test 94 98 800 804 O

Has 0 3 805 808 O
a 4 5 809 810 O
history 6 13 811 818 O
of 14 16 819 821 O
( 17 18 822 823 O
non 18 21 823 826 O
- 21 22 826 827 O
infectious 22 32 827 837 O
) 32 33 837 838 O
pneumonitis 34 45 839 850 B-chronic_disease
that 46 50 851 855 O
required 51 59 856 864 O
steroids 60 68 865 873 B-treatment
or 69 71 874 876 O
current 72 79 877 884 O
pneumonitis 80 91 885 896 O

Has 0 3 897 900 O
undergone 4 13 901 910 O
solid 14 19 911 916 B-treatment
organ 20 25 917 922 I-treatment
transplant 26 36 923 933 I-treatment
at 37 39 934 936 O
any 40 43 937 940 O
time 44 48 941 945 O

Hepatitis 0 9 946 955 B-chronic_disease
B 10 11 956 957 I-chronic_disease
or 12 14 958 960 I-chronic_disease
C 15 16 961 962 I-chronic_disease

Histologically- 0 15 963 978 O
or 16 18 979 981 O
cytologically 19 32 982 995 O
- 32 33 995 996 O
documented 33 43 996 1006 O
, 43 44 1006 1007 O
locally 45 52 1008 1015 O
- 52 53 1015 1016 O
advanced 53 61 1016 1024 O
, 61 62 1024 1025 O
or 63 65 1026 1028 O
metastatic 66 76 1029 1039 B-cancer
solid 77 82 1040 1045 I-cancer
malignancy 83 93 1046 1056 I-cancer
or 94 96 1057 1059 O
lymphoma 97 105 1060 1068 B-cancer
that 106 110 1069 1073 O
is 111 113 1074 1076 O
incurable 114 123 1077 1086 O

History 0 7 1087 1094 O
or 8 10 1095 1097 O
current 11 18 1098 1105 O
evidence 19 27 1106 1114 O
of 28 30 1115 1117 O
any 31 34 1118 1121 O
condition 35 44 1122 1131 O
, 44 45 1131 1132 O
therapy 46 53 1133 1140 B-treatment
, 53 54 1140 1141 O
or 55 57 1142 1144 O
laboratory 58 68 1145 1155 O
abnormality 69 80 1156 1167 O

Human 0 5 1168 1173 B-chronic_disease
immunodeficiency 6 22 1174 1190 I-chronic_disease
virus 23 28 1191 1196 I-chronic_disease
( 29 30 1197 1198 I-chronic_disease
HIV 30 33 1198 1201 I-chronic_disease
) 33 34 1201 1202 I-chronic_disease

Karnofsky 0 9 1203 1212 B-clinical_variable
score 10 15 1213 1218 I-clinical_variable
≥50 16 19 1219 1222 O
for 20 23 1223 1226 O
participants 24 36 1227 1239 O
> 37 38 1240 1241 O
16 38 40 1241 1243 B-lower_bound
years 41 46 1244 1249 I-lower_bound
of 47 49 1250 1252 O
age 50 53 1253 1256 B-age

Known 0 5 1257 1262 O
active 6 12 1263 1269 O
central 13 20 1270 1277 B-cancer
nervous 21 28 1278 1285 I-cancer
system 29 35 1286 1292 I-cancer
( 36 37 1293 1294 I-cancer
CNS 37 40 1294 1297 I-cancer
) 40 41 1297 1298 I-cancer
metastases 42 52 1299 1309 I-cancer
and/or 53 59 1310 1316 O
carcinomatous 60 73 1317 1330 B-cancer
meningitis 74 84 1331 1341 I-cancer

Known 0 5 1342 1347 O
additional 6 16 1348 1358 O
malignancy 17 27 1359 1369 B-cancer
that 28 32 1370 1374 O
is 33 35 1375 1377 O
progressing 36 47 1378 1389 O
or 48 50 1390 1392 O
requires 51 59 1393 1401 O
active 60 66 1402 1408 O
treatment 67 76 1409 1418 B-treatment
with 77 81 1419 1423 O
the 82 85 1424 1427 O
exception 86 95 1428 1437 O
of 96 98 1438 1440 O
basal 99 104 1441 1446 B-cancer
cell 105 109 1447 1451 I-cancer
carcinoma 110 119 1452 1461 I-cancer
of 120 122 1462 1464 I-cancer
the 123 126 1465 1468 I-cancer
skin 127 131 1469 1473 I-cancer
, 131 132 1473 1474 O
squamous 133 141 1475 1483 B-cancer
cell 142 146 1484 1488 I-cancer
carcinoma 147 156 1489 1498 I-cancer
of 157 159 1499 1501 I-cancer
the 160 163 1502 1505 I-cancer
skin 164 168 1506 1510 I-cancer
or 169 171 1511 1513 O
carcinoma 172 181 1514 1523 B-cancer
in 182 184 1524 1526 I-cancer
situ 185 189 1527 1531 I-cancer

Known 0 5 1532 1537 O
history 6 13 1538 1545 O
of 14 16 1546 1548 O
active 17 23 1549 1555 B-chronic_disease
tuberculosis 24 36 1556 1568 I-chronic_disease
( 37 38 1569 1570 O
TB 38 40 1570 1572 B-chronic_disease
; 40 41 1572 1573 O
Bacillus 42 50 1574 1582 B-chronic_disease
tuberculosis 51 63 1583 1595 I-chronic_disease
) 63 64 1595 1596 O

Known 0 5 1597 1602 O
psychiatric 6 17 1603 1614 B-chronic_disease
or 18 20 1615 1617 O
substance 21 30 1618 1627 O
abuse 31 36 1628 1633 O
disorders 37 46 1634 1643 O
that 47 51 1644 1648 O
would 52 57 1649 1654 O
interfere 58 67 1655 1664 O
with 68 72 1665 1669 O
the 73 76 1670 1673 O
requirements 77 89 1674 1686 O
of 90 92 1687 1689 O
the 93 96 1690 1693 O
study 97 102 1694 1699 O

Lansky 0 6 1700 1706 B-clinical_variable
Play 7 11 1707 1711 I-clinical_variable
Scale 12 17 1712 1717 I-clinical_variable
≥50 18 21 1718 1721 O
for 22 25 1722 1725 O
participants 26 38 1726 1738 O
from 39 43 1739 1743 O
6 44 45 1744 1745 B-lower_bound
months 46 52 1746 1752 I-lower_bound
up 53 55 1753 1755 O
to 56 58 1756 1758 O
and 59 62 1759 1762 O
including 63 72 1763 1772 O
16 73 75 1773 1775 B-upper_bound
years 76 81 1776 1781 I-upper_bound
of 82 84 1782 1784 O
age 85 88 1785 1788 B-age

Male 0 4 1789 1793 B-gender
participants 5 17 1794 1806 I-gender
of 18 20 1807 1809 O
reproductive 21 33 1810 1822 O
potential 34 43 1823 1832 O
must 44 48 1833 1837 O
agree 49 54 1838 1843 B-contraception_consent
to 55 57 1844 1846 I-contraception_consent
use 58 61 1847 1850 I-contraception_consent
an 62 64 1851 1853 I-contraception_consent
adequate 65 73 1854 1862 I-contraception_consent
method 74 80 1863 1869 I-contraception_consent
of 81 83 1870 1872 I-contraception_consent
contraception 84 97 1873 1886 I-contraception_consent
starting 98 106 1887 1895 O
with 107 111 1896 1900 O
the 112 115 1901 1904 O
first 116 121 1905 1910 O
dose 122 126 1911 1915 O
of 127 129 1916 1918 O
study 130 135 1919 1924 B-treatment
medication 136 146 1925 1935 I-treatment
through 147 154 1936 1943 O
120 155 158 1944 1947 B-upper_bound
days 159 163 1948 1952 I-upper_bound
after 164 169 1953 1958 O
the 170 173 1959 1962 O
last 174 178 1963 1967 O
dose 179 183 1968 1972 O
of 184 186 1973 1975 O
study 187 192 1976 1981 O
medication 193 203 1982 1992 O

Participants 0 12 1993 2005 O
who 13 16 2006 2009 O
have 17 21 2010 2014 O
had 22 25 2015 2018 O
an 26 28 2019 2021 O
allogeneic 29 39 2022 2032 B-treatment
hematopoietic 40 53 2033 2046 I-treatment
transplant 54 64 2047 2057 I-treatment
> 65 66 2058 2059 O
5 66 67 2059 2060 B-lower_bound
years 68 73 2061 2066 I-lower_bound
ago 74 77 2067 2070 I-lower_bound
are 78 81 2071 2074 O
eligible 82 90 2075 2083 O
as 91 93 2084 2086 O
long 94 98 2087 2091 O
as 99 101 2092 2094 O
there 102 107 2095 2100 O
are 108 111 2101 2104 O
no 112 114 2105 2107 O
symptoms 115 123 2108 2116 O
of 124 126 2117 2119 O
Graft 127 132 2120 2125 B-chronic_disease
Versus 133 139 2126 2132 I-chronic_disease
Host 140 144 2133 2137 I-chronic_disease
Disease 145 152 2138 2145 I-chronic_disease
[ 153 154 2146 2147 I-chronic_disease
GVHD 154 158 2147 2151 I-chronic_disease
] 158 159 2151 2152 I-chronic_disease

Participants 0 12 2153 2165 O
with 13 17 2166 2170 O
neuroblastoma 18 31 2171 2184 B-cancer
with 32 36 2185 2189 O
only 37 41 2190 2194 O
metaiodobenzylguanidine 42 65 2195 2218 B-treatment
( 66 67 2219 2220 I-treatment
MIBG)-positive 67 81 2220 2234 I-treatment
evaluable 82 91 2235 2244 O
disease 92 99 2245 2252 O
may 100 103 2253 2256 O
be 104 106 2257 2259 O
enrolled 107 115 2260 2268 O

Pregnant 0 8 2269 2277 B-pregnancy

Prior 0 5 2278 2283 B-treatment
radiotherapy 6 18 2284 2296 I-treatment
within 19 25 2297 2303 O
2 26 27 2304 2305 B-upper_bound
weeks 28 33 2306 2311 I-upper_bound
of 34 36 2312 2314 O
start 37 42 2315 2320 O
of 43 45 2321 2323 O
study 46 51 2324 2329 O
treatment 52 61 2330 2339 B-treatment

Prior 0 5 2340 2345 B-treatment
systemic 6 14 2346 2354 I-treatment
anti 15 19 2355 2359 I-treatment
- 19 20 2359 2360 I-treatment
cancer 20 26 2360 2366 I-treatment
therapy 27 34 2367 2374 I-treatment
including 35 44 2375 2384 O
investigational 45 60 2385 2400 B-treatment
agent 61 66 2401 2406 I-treatment

Prior 0 5 2407 2412 B-treatment
therapy 6 13 2413 2420 I-treatment
with 14 18 2421 2425 O
an 19 21 2426 2428 O
anti 22 26 2429 2433 O
- 26 27 2433 2434 O
programmed 27 37 2434 2444 O
cell 38 42 2445 2449 O
death 43 48 2450 2455 O
( 49 50 2456 2457 O
PD)-1 50 55 2457 2462 O
, 55 56 2462 2463 O
anti 57 61 2464 2468 O
- 61 62 2468 2469 O
PD 62 64 2469 2471 O
- 64 65 2471 2472 O
ligand 65 71 2472 2478 O
1 72 73 2479 2480 O
( 74 75 2481 2482 O
anti 75 79 2482 2486 O
- 79 80 2486 2487 O
PD 80 82 2487 2489 O
- 82 83 2489 2490 O
L1 83 85 2490 2492 O
) 85 86 2492 2493 O
, 86 87 2493 2494 O
anti 88 92 2495 2499 O
- 92 93 2499 2500 O
PD 93 95 2500 2502 O
- 95 96 2502 2503 O
L2 96 98 2503 2505 O
agent 99 104 2506 2511 O

Received 0 8 2512 2520 O
a 9 10 2521 2522 O
live 11 15 2523 2527 O
vaccine 16 23 2528 2535 B-treatment
within 24 30 2536 2542 O
30 31 33 2543 2545 B-upper_bound
days 34 38 2546 2550 I-upper_bound
of 39 41 2551 2553 O
planned 42 49 2554 2561 O
start 50 55 2562 2567 O
of 56 58 2568 2570 O
study 59 64 2571 2576 O
medication 65 75 2577 2587 B-treatment

Severe 0 6 2588 2594 O
hypersensitivity 7 23 2595 2611 O
( 24 25 2612 2613 O
≥ 25 26 2613 2614 O
Grade 27 32 2615 2620 B-lower_bound
3 33 34 2621 2622 I-lower_bound
) 34 35 2622 2623 O
to 36 38 2624 2626 O
pembrolizumab 39 52 2627 2640 B-allergy_name
and/or 53 59 2641 2647 O
any 60 63 2648 2651 O
of 64 66 2652 2654 O
its 67 70 2655 2658 O
excipients 71 81 2659 2669 B-allergy_name

Tissue 0 6 2670 2676 O
( 7 8 2677 2678 O
or 8 10 2678 2680 O
lymph 11 16 2681 2686 B-treatment
node 17 21 2687 2691 I-treatment
biopsy 22 28 2692 2698 I-treatment
for 29 32 2699 2702 O
rrcHL 33 38 2703 2708 B-cancer
participants 39 51 2709 2721 O
) 51 52 2721 2722 O
available 53 62 2723 2732 O
from 63 67 2733 2737 O
an 68 70 2738 2740 O
archival 71 79 2741 2749 O
tissue 80 86 2750 2756 O
sample 87 93 2757 2763 O

Tumor(s 0 7 2764 2771 B-cancer
) 7 8 2771 2772 I-cancer
involving 9 18 2773 2782 O
the 19 22 2783 2786 O
brain 23 28 2787 2792 O
stem 29 33 2793 2797 O

abstain 0 7 2798 2805 O
from 8 12 2806 2810 O
heterosexual 13 25 2811 2823 O
activity 26 34 2824 2832 O
for 35 38 2833 2836 O
the 39 42 2837 2840 O
course 43 49 2841 2847 O
of 50 52 2848 2850 O
the 53 56 2851 2854 O
study 57 62 2855 2860 O
through 63 70 2861 2868 O
120 71 74 2869 2872 B-upper_bound
days 75 79 2873 2877 I-upper_bound
after 80 85 2878 2883 I-upper_bound
the 86 89 2884 2887 O
last 90 94 2888 2892 O
dose 95 99 2893 2897 O
of 100 102 2898 2900 O
study 103 108 2901 2906 O
medication 109 119 2907 2917 B-treatment

between 0 7 2918 2925 O
3 8 9 2926 2927 B-lower_bound
years 10 15 2928 2933 I-lower_bound
and 16 19 2934 2937 O
< 20 21 2938 2939 O
18 21 23 2939 2941 B-upper_bound
years 24 29 2942 2947 I-upper_bound
of 30 32 2948 2950 O
age 33 36 2951 2954 B-age
for 37 40 2955 2958 O
rrcHL 41 46 2959 2964 B-cancer
participants 47 59 2965 2977 O

expecting 0 9 2978 2987 O
to 10 12 2988 2990 O
conceive 13 21 2991 2999 O
or 22 24 3000 3002 O
father 25 31 3003 3009 O
children 32 40 3010 3018 O
within 41 47 3019 3025 O
the 48 51 3026 3029 O
projected 52 61 3030 3039 O
duration 62 70 3040 3048 O
of 71 73 3049 3051 O
the 74 77 3052 3055 O
trial 78 83 3056 3061 O
through 84 91 3062 3069 O
120 92 95 3070 3073 B-upper_bound
days 96 100 3074 3078 I-upper_bound
after 101 106 3079 3084 I-upper_bound
the 107 110 3085 3088 O
last 111 115 3089 3093 O
dose 116 120 3094 3098 O
of 121 123 3099 3101 O
study 124 129 3102 3107 B-treatment
medication 130 140 3108 3118 I-treatment

for 0 3 3119 3122 O
which 4 9 3123 3128 O
no 10 12 3129 3131 O
standard 13 21 3132 3140 O
therapy 22 29 3141 3148 B-treatment
exists 30 36 3149 3155 O

for 0 3 3156 3159 O
which 4 9 3160 3165 O
no 10 12 3166 3168 O
standard 13 21 3169 3177 O
therapy 22 29 3178 3185 B-treatment
is 30 32 3186 3188 O
considered 33 43 3189 3199 O
appropriate 44 55 3200 3211 O

has 0 3 3212 3215 O
failed 4 10 3216 3222 O
prior 11 16 3223 3228 B-treatment
standard 17 25 3229 3237 I-treatment
therapy 26 33 3238 3245 I-treatment

known 0 5 3246 3251 O
severe 6 12 3252 3258 O
hypersensitivity 13 29 3259 3275 O
to 30 32 3276 3278 O
any 33 36 3279 3282 O
component 37 46 3283 3292 B-allergy_name
or 47 49 3293 3295 I-allergy_name
analog 50 56 3296 3302 I-allergy_name
of 57 59 3303 3305 I-allergy_name
the 60 63 3306 3309 I-allergy_name
trial 64 69 3310 3315 I-allergy_name
treatment 70 79 3316 3325 I-allergy_name
, 79 80 3325 3326 O
that 81 85 3327 3331 O
might 86 91 3332 3337 O
confound 92 100 3338 3346 O
the 101 104 3347 3350 O
results 105 112 3351 3358 O
of 113 115 3359 3361 O
the 116 119 3362 3365 O
trial 120 125 3366 3371 O

measurement 0 11 3372 3383 O
must 12 16 3384 3388 O
be 17 19 3389 3391 O
> 20 21 3392 3393 O
15 21 23 3393 3395 B-lower_bound
mm 24 26 3396 3398 I-lower_bound
in 27 29 3399 3401 O
longest 30 37 3402 3409 O
diameter 38 46 3410 3418 O
or 47 49 3419 3421 O
> 50 51 3422 3423 O
10 51 53 3423 3425 B-lower_bound
mm 54 56 3426 3428 I-lower_bound
in 57 59 3429 3431 O
short 60 65 3432 3437 O
axis 66 70 3438 3442 O
] 70 71 3442 3443 O
for 72 75 3444 3447 O
rrcHL 76 81 3448 3453 O
participants 82 94 3454 3466 O

on 0 2 3467 3469 O
day 3 6 3470 3473 O
of 7 9 3474 3476 O
signing 10 17 3477 3484 O
informed 18 26 3485 3493 O
consent 27 34 3494 3501 O
/ 34 35 3501 3502 O
assent 35 41 3502 3508 O
( 42 43 3509 3510 O
the 43 46 3510 3513 O
first 47 52 3514 3519 O
3 53 54 3520 3521 O
participants 55 67 3522 3534 O
dosed 68 73 3535 3540 O
in 74 76 3541 3543 O
Part 77 81 3544 3548 O
1 82 83 3549 3550 O
are 84 87 3551 3554 O
to 88 90 3555 3557 O
be 91 93 3558 3560 O
≥ 94 95 3561 3562 O
6 96 97 3563 3564 B-lower_bound
years 98 103 3565 3570 I-lower_bound
of 104 106 3571 3573 O
age 107 110 3574 3577 B-age
) 110 111 3577 3578 O

prior 0 5 3579 3584 B-treatment
allogeneic 6 16 3585 3595 I-treatment
hematopoietic 17 30 3596 3609 I-treatment
stem 31 35 3610 3614 I-treatment
cell 36 40 3615 3619 I-treatment
transplantation 41 56 3620 3635 I-treatment
within 57 63 3636 3642 O
the 64 67 3643 3646 O
last 68 72 3647 3651 B-upper_bound
5 73 74 3652 3653 I-upper_bound
years 75 80 3654 3659 I-upper_bound

replacement 0 11 3660 3671 B-treatment
therapy 12 19 3672 3679 I-treatment
( 20 21 3680 3681 O
such 21 25 3681 3685 O
as 26 28 3686 3688 O
thyroxine 29 38 3689 3698 B-treatment
, 38 39 3698 3699 O
insulin 40 47 3700 3707 B-treatment
, 47 48 3707 3708 O
or 49 51 3709 3711 O
physiologic 52 63 3712 3723 B-treatment
corticosteroid 64 78 3724 3738 I-treatment
replacement 79 90 3739 3750 I-treatment
therapy 91 98 3751 3758 I-treatment
for 99 102 3759 3762 O
adrenal 103 110 3763 3770 B-chronic_disease
or 111 113 3771 3773 O
pituitary 114 123 3774 3783 B-chronic_disease
insufficiency 124 137 3784 3797 I-chronic_disease
) 137 138 3797 3798 O
is 139 141 3799 3801 O
acceptable 142 152 3802 3812 O

with 0 4 3813 3817 O
potentially 5 16 3818 3829 B-treatment
curative 17 25 3830 3838 I-treatment
therapy 26 33 3839 3846 I-treatment
, 33 34 3846 3847 O
or 35 37 3848 3850 O
in 38 40 3851 3853 B-cancer
situ 41 45 3854 3858 I-cancer
cervical 46 54 3859 3867 I-cancer
cancer 55 61 3868 3874 I-cancer

within 0 6 3875 3881 O
7 7 8 3882 3883 B-upper_bound
days 9 13 3884 3888 I-upper_bound
prior 14 19 3889 3894 I-upper_bound
to 20 22 3895 3897 O
the 23 26 3898 3901 O
date 27 31 3902 3906 O
of 32 34 3907 3909 O
allocation 35 45 3910 3920 O
/ 45 46 3920 3921 O
randomization 46 59 3921 3934 O

within 0 6 3935 3941 O
72 7 9 3942 3944 B-upper_bound
hours 10 15 3945 3950 I-upper_bound
prior 16 21 3951 3956 I-upper_bound
to 22 24 3957 3959 O
receiving 25 34 3960 3969 O
the 35 38 3970 3973 O
first 39 44 3974 3979 O
dose 45 49 3980 3984 O
of 50 52 3985 3987 O
study 53 58 3988 3993 O
medication 59 69 3994 4004 B-treatment

